| Year |
Citation |
Score |
| 2023 |
Teshima T, Hashimoto D. Separation of GVL from GVHD -location, location, location. Frontiers in Immunology. 14: 1296663. PMID 38116007 DOI: 10.3389/fimmu.2023.1296663 |
0.309 |
|
| 2020 |
Goto H, Hidaka D, Yamamoto S, Hayasaka K, Michimata R, Kagawa I, Sunagoya K, Iijima H, Hayase E, Shiratori S, Okada K, Sugita J, Onozawa M, Hashimoto D, Kahata K, et al. Feasibility and efficacy of low-dose pegfilgrastim for CD34 cell mobilization in lymphoma. Journal of Clinical Apheresis. 35: 413-419. PMID 33043486 DOI: 10.1002/Jca.21816 |
0.34 |
|
| 2020 |
Hashimoto D. [Graft-versus-host disease: new insights into disease pathogenesis]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 61: 959-964. PMID 32908061 DOI: 10.11406/Rinketsu.61.959 |
0.388 |
|
| 2020 |
Ara T, Hashimoto D, Hayase E, Noizat C, Kikuchi R, Hasegawa Y, Matsuda K, Ono S, Matsuno Y, Ebata K, Ogasawara R, Takahashi S, Ohigashi H, Yokoyama E, Matsuo K, et al. Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8. Science Translational Medicine. 12. PMID 32611682 DOI: 10.1126/Scitranslmed.Aaw0720 |
0.373 |
|
| 2020 |
Hashimoto D. [Animal models in the study of allogeneic hematopoietic stem cell transplantation]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 61: 369-378. PMID 32378583 DOI: 10.11406/Rinketsu.61.369 |
0.339 |
|
| 2020 |
Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. The New England Journal of Medicine. 382: 822-834. PMID 32101664 DOI: 10.1056/Nejmoa1900623 |
0.306 |
|
| 2019 |
Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, Staffas A, Burgos da Silva M, Devlin SM, Markey KA, Bajic D, ... ... Hashimoto D, et al. Lactose drives expansion to promote graft-versus-host disease. Science (New York, N.Y.). 366: 1143-1149. PMID 31780560 DOI: 10.1126/Science.Aax3760 |
0.335 |
|
| 2019 |
Yokoyama E, Hashimoto D, Hayase E, Ara T, Ogasawara R, Takahashi S, Ohigashi H, Tateno T, Hasegawa Y, Chen X, Teshima T. Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis. Bone Marrow Transplantation. PMID 31685933 DOI: 10.1038/S41409-019-0733-8 |
0.359 |
|
| 2019 |
Yamahara K, Hamada A, Soma T, Okamoto R, Okada M, Yoshihara S, Yoshihara K, Ikegame K, Tamaki H, Kaida K, Inoue T, Ohsugi Y, Nishikawa H, Hayashi H, Ito YM, ... ... Hashimoto D, et al. Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. Bmj Open. 9: e026403. PMID 31289066 DOI: 10.1136/Bmjopen-2018-026403 |
0.352 |
|
| 2019 |
Matsuoka S, Hashimoto D, Kadowaki M, Ohigashi H, Hayase E, Yokoyama E, Hasegawa Y, Tateno T, Chen X, Aoyama K, Oka H, Onozawa M, Takeda K, Akashi K, Teshima T. The myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease. Haematologica. PMID 31048358 DOI: 10.3324/Haematol.2018.203380 |
0.41 |
|
| 2019 |
Hidaka D, Onozawa M, Miyashita N, Nakagawa M, Hashimoto D, Teshima T. Imetelstat Sensitizes Hematopoietic Malignancy Cells to Genotoxic Agent Via Suppression of Telomerase Mediated DNA Repair Process Blood. 134: 3369-3369. DOI: 10.1182/Blood-2019-122999 |
0.302 |
|
| 2018 |
Hashimoto D. [Niche signals regulate differentiation and functions of tissue resident macrophages]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 59: 1886-1894. PMID 30305489 DOI: 10.11406/Rinketsu.59.1886 |
0.39 |
|
| 2018 |
Eriguchi Y, Nakamura K, Yokoi Y, Sugimoto R, Takahashi S, Hashimoto D, Teshima T, Ayabe T, Selsted ME, Ouellette AJ. Essential role of IFN-γ in T cell-associated intestinal inflammation. Jci Insight. 3. PMID 30232288 DOI: 10.1172/Jci.Insight.121886 |
0.385 |
|
| 2018 |
Hidaka D, Hayase E, Shiratori S, Hasegawa Y, Ishio T, Tateno T, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Endo T, Hashimoto D, Teshima T. The association between the incidence of intestinal graft-versus-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation. Clinical Transplantation. e13361. PMID 30054935 DOI: 10.1111/Ctr.13361 |
0.331 |
|
| 2018 |
Ogasawara R, Hashimoto D, Kimura S, Hayase E, Ara T, Takahashi S, Ohigashi H, Yoshioka K, Tateno T, Yokoyama E, Ebata K, Kondo T, Sugita J, Onozawa M, Iwanaga T, et al. Intestinal Lymphatic Endothelial Cells Produce R-Spondin3. Scientific Reports. 8: 10719. PMID 30013036 DOI: 10.1038/S41598-018-29100-7 |
0.311 |
|
| 2018 |
Ishio T, Sugita J, Tateno T, Hidaka D, Hayase E, Shiratori S, Okada K, Goto H, Onozawa M, Nakagawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Kondo T, et al. Hematogones predict better outcome in allogeneic hematopoietic stem cell transplantation irrespective of graft sources. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29909151 DOI: 10.1016/J.Bbmt.2018.06.011 |
0.323 |
|
| 2018 |
Yamakawa T, Ohigashi H, Hashimoto D, Hayase E, Takahashi S, Miyazaki M, Minomi K, Onozawa M, Niitsu Y, Teshima T. Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease. Blood. PMID 29363541 DOI: 10.1182/Blood-2017-04-779934 |
0.305 |
|
| 2018 |
Stein-Thoeringer CK, Peled JU, Gomes AL, Lazrak A, Docampo MD, Slingerland AE, Nichols K, Shono Y, Weber D, Sung AD, Hashimoto D, Cross J, Teshima T, Holler E, Chao NJ, et al. Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd Blood. 132: 358-358. DOI: 10.1182/Blood-2018-99-119887 |
0.352 |
|
| 2018 |
Ara T, Hashimoto D, Hayase E, Clara N, Okumura R, Takeda K, Teshima T. Intestinal Goblet Cells Play a Protective Role Against GVHD Via a Lypd8-Dependent Manner after Allogeneic Hematopoietic Stem Cell Transplantation Blood. 132: 64-64. DOI: 10.1182/Blood-2018-99-115510 |
0.38 |
|
| 2018 |
Ogasawara R, Hashimoto D, Hayase E, Ebata K, Takahashi S, Ara T, Ohigashi H, Teshima T. Graft-Versus-Host Disease Targets R-Spondin3-Producing Lymphatic Endothelial Cells in the Small Intestine Biology of Blood and Marrow Transplantation. 24: S178-S179. DOI: 10.1016/J.Bbmt.2017.12.129 |
0.308 |
|
| 2018 |
Ara T, Hashimoto D, Hayase E, Noizat C, Matsuda K, Ono S, Matsuno Y, Teshima T. Degree of Intestinal Goblet-Cell Loss is Associated with Severity of Gvhd and Transplant Outcome, and Goblet Cell Growth Factor IL-25 Mitigates Gvhd Biology of Blood and Marrow Transplantation. 24: S169-S170. DOI: 10.1016/J.Bbmt.2017.12.117 |
0.315 |
|
| 2017 |
Shiratori S, Kosugi-Kanaya M, Hayase E, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Hashimoto D, Endo T, Kondo T, Teshima T. T-cell depletion effects of low-dose antithymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation. Transplant Immunology. PMID 29128394 DOI: 10.1016/J.Trim.2017.11.001 |
0.351 |
|
| 2017 |
Hayase E, Hashimoto D, Nakamura K, Noizat C, Ogasawara R, Takahashi S, Ohigashi H, Yokoi Y, Sugimoto R, Matsuoka S, Ara T, Yokoyama E, Yamakawa T, Ebata K, Kondo T, et al. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease. The Journal of Experimental Medicine. PMID 29066578 DOI: 10.1084/Jem.20170418 |
0.34 |
|
| 2017 |
Shimoji S, Hashimoto D, Teshima T. Graft-versus-host disease in the ovary potentially causes female infertility after allogeneic hematopoietic stem cell transplantation. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 58: 827-834. PMID 28781281 DOI: 10.11406/Rinketsu.58.827 |
0.326 |
|
| 2017 |
Miyashita N, Endo T, Onozawa M, Hashimoto D, Kondo T, Fujimoto K, Kahata K, Sugita J, Goto H, Matsukawa T, Hashino S, Teshima T. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease : An Official Journal of the Transplantation Society. PMID 28207973 DOI: 10.1111/Tid.12682 |
0.314 |
|
| 2016 |
Shimoji S, Hashimoto D, Tsujigiwa H, Miyawaki K, Kato K, Takahashi S, Ogasawara R, Jiromaru T, Iwasaki H, Miyamoto T, Akashi K, Teshima T. Graft-versus-host disease targets ovary and causes female infertility in mice. Blood. PMID 27903524 DOI: 10.1182/Blood-2016-07-728337 |
0.357 |
|
| 2016 |
Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, Chakarov S, Rivera C, Hogstad B, Bosenberg M, Hashimoto D, et al. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. Immunity. 44: 924-38. PMID 27096321 DOI: 10.1016/J.Immuni.2016.03.012 |
0.777 |
|
| 2015 |
Ochando J, Kwan WH, Ginhoux F, Hutchinson JA, Hashimoto D, Collin M. The mononuclear phagocyte system in organ transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 26602545 DOI: 10.1111/Ajt.13627 |
0.714 |
|
| 2015 |
Hashimoto D, Teshima T. Key players in intestinal GVHD [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology. 56: 807-814. PMID 26251143 DOI: 10.11406/Rinketsu.56.807 |
0.388 |
|
| 2015 |
Eriguchi Y, Nakamura K, Hashimoto D, Shimoda S, Shimono N, Akashi K, Ayabe T, Teshima T. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 17: 702-6. PMID 26198302 DOI: 10.1111/Tid.12423 |
0.337 |
|
| 2015 |
Uryu H, Hashimoto D, Kato K, Hayase E, Matsuoka S, Ogasawara R, Takahashi S, Maeda Y, Iwasaki H, Miyamoto T, Saijo S, Iwakura Y, Hill GR, Akashi K, Teshima T. α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice. Blood. 125: 3014-23. PMID 25740827 DOI: 10.1182/Blood-2014-12-615781 |
0.364 |
|
| 2015 |
Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, Wolchok J, Bhardwaj N, Merad M, Saenger Y. Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy. Cancer Immunology Research. 3: 296-304. PMID 25600438 DOI: 10.1158/2326-6066.Cir-14-0120 |
0.732 |
|
| 2015 |
Hayase E, Hashimoto D, Nakamura K, Ogura Y, Hayashi T, Kurokawa K, Ayabe T, Teshima T. R-spondin1 Promotes Paneth Cell Growth, Maintains Intestinal Microbial Ecology, and Ameliorates GvHD Blood. 126: 230-230. DOI: 10.1182/Blood.V126.23.230.230 |
0.328 |
|
| 2015 |
Shimoji S, Hashimoto D, Kato K, Tujigiwa H, Akashi K, Teshima T. Graft-Versus-Host Disease Targets Granulosa Cell of Ovarian Follicle and Causes Infertility after Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 21: S26-S27. DOI: 10.1016/J.Bbmt.2014.11.014 |
0.35 |
|
| 2014 |
Muller PA, Koscsó B, Rajani GM, Stevanovic K, Berres ML, Hashimoto D, Mortha A, Leboeuf M, Li XM, Mucida D, Stanley ER, Dahan S, Margolis KG, Gershon MD, Merad M, et al. Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility. Cell. 158: 1210. PMID 28917294 DOI: 10.1016/J.Cell.2014.08.002 |
0.76 |
|
| 2014 |
Muller PA, Koscsó B, Rajani GM, Stevanovic K, Berres ML, Hashimoto D, Mortha A, Leboeuf M, Li XM, Mucida D, Stanley ER, Dahan S, Margolis KG, Gershon MD, Merad M, et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell. 158: 300-13. PMID 25036630 DOI: 10.1016/J.Cell.2014.04.050 |
0.773 |
|
| 2014 |
Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, Merad M. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science (New York, N.Y.). 343: 1249288. PMID 24625929 DOI: 10.1126/Science.1249288 |
0.806 |
|
| 2014 |
Jiao J, Dragomir AC, Kocabayoglu P, Rahman AH, Chow A, Hashimoto D, Leboeuf M, Kraus T, Moran T, Carrasco-Avino G, Friedman SL, Merad M, Aloman C. Central role of conventional dendritic cells in regulation of bone marrow release and survival of neutrophils. Journal of Immunology (Baltimore, Md. : 1950). 192: 3374-82. PMID 24591364 DOI: 10.4049/Jimmunol.1300237 |
0.75 |
|
| 2014 |
Bongers G, Pacer ME, Geraldino TH, Chen L, He Z, Hashimoto D, Furtado GC, Ochando J, Kelley KA, Clemente JC, Merad M, van Bakel H, Lira SA. Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. The Journal of Experimental Medicine. 211: 457-72. PMID 24590763 DOI: 10.1084/Jem.20131587 |
0.515 |
|
| 2014 |
Shono Y, Shiratori S, Kosugi-Kanaya M, Ueha S, Sugita J, Shigematsu A, Kondo T, Hashimoto D, Fujimoto K, Endo T, Nishio M, Hashino S, Matsuno Y, Matsushima K, Tanaka J, et al. Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 495-500. PMID 24374213 DOI: 10.1016/J.Bbmt.2013.12.568 |
0.405 |
|
| 2014 |
Agudo J, Ruzo A, Tung N, Salmon H, Leboeuf M, Hashimoto D, Becker C, Garrett-Sinha LA, Baccarini A, Merad M, Brown BD. The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nature Immunology. 15: 54-62. PMID 24270517 DOI: 10.1038/Ni.2767 |
0.753 |
|
| 2014 |
Koyama M, Hashimoto D, Nagafuji K, Eto T, Ohno Y, Aoyama K, Iwasaki H, Miyamoto T, Hill GR, Akashi K, Teshima T. Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning. Bone Marrow Transplantation. 49: 110-5. PMID 24013691 DOI: 10.1038/Bmt.2013.134 |
0.377 |
|
| 2013 |
Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T. Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1525-9. PMID 23927965 DOI: 10.1016/J.Bbmt.2013.07.027 |
0.349 |
|
| 2013 |
Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, Greter M, Mortha A, Boyer SW, Forsberg EC, Tanaka M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 38: 792-804. PMID 23601688 DOI: 10.1016/J.Immuni.2013.04.004 |
0.777 |
|
| 2013 |
Chow A, Huggins M, Ahmed J, Hashimoto D, Lucas D, Kunisaki Y, Pinho S, Leboeuf M, Noizat C, van Rooijen N, Tanaka M, Zhao ZJ, Bergman A, Merad M, Frenette PS. CD169⺠macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nature Medicine. 19: 429-36. PMID 23502962 DOI: 10.1038/Nm.3057 |
0.804 |
|
| 2013 |
Shimoji S, Kato K, Tsujigiwa H, Eriguchi Y, Lee L, Uryu H, Takashima S, Hashimoto D, Akashi K, Teshima T. Graft-Versus-Host Disease Targets Ovary and Causes Infertility After Allogeneic Hematopoietic Stem Cell Transplantation Blood. 122: 4470-4470. DOI: 10.1182/Blood.V122.21.4470.4470 |
0.383 |
|
| 2013 |
Moskalenko M, Pan M, Hashimoto D, Mortha A, Bernardo SG, Leboeuf M, Houghton A, Wolchok J, Burakoff S, Merad M, Saenger YM. Abstract A43: Therapeutic efficacy of antitumor monoclonal antibodies combined with chemotherapy depends on innate immunity and NK1.1- innate lymphoid cells. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A43 |
0.74 |
|
| 2012 |
Helft J, Manicassamy B, Guermonprez P, Hashimoto D, Silvin A, Agudo J, Brown BD, Schmolke M, Miller JC, Leboeuf M, Murphy KM, García-Sastre A, Merad M. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. The Journal of Clinical Investigation. 122: 4037-47. PMID 23041628 DOI: 10.1172/Jci60659 |
0.758 |
|
| 2012 |
Scheiermann C, Kunisaki Y, Lucas D, Chow A, Jang JE, Zhang D, Hashimoto D, Merad M, Frenette PS. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity. 37: 290-301. PMID 22863835 DOI: 10.1016/J.Immuni.2012.05.021 |
0.701 |
|
| 2012 |
Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, Pandey G, Leboeuf M, Elpek KG, Helft J, Hashimoto D, Chow A, Price J, Greter M, Bogunovic M, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nature Immunology. 13: 888-99. PMID 22797772 DOI: 10.1038/Ni.2370 |
0.786 |
|
| 2012 |
Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J, Bogunovic M, Gautier EL, Miller J, Leboeuf M, Lu G, Aloman C, Brown BD, Pollard JW, Xiong H, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity. 36: 1031-46. PMID 22749353 DOI: 10.1016/J.Immuni.2012.03.027 |
0.8 |
|
| 2012 |
Kwan WH, Hashimoto D, Paz-Artal E, Ostrow K, Greter M, Raedler H, Medof ME, Merad M, Heeger PS. Antigen-presenting cell-derived complement modulates graft-versus-host disease. The Journal of Clinical Investigation. 122: 2234-8. PMID 22585573 DOI: 10.1172/Jci61019 |
0.729 |
|
| 2012 |
Singh G, Hashimoto D, Yan X, Helft J, Park PJ, Ma G, Qiao RF, Kennedy CR, Chen SH, Merad M, Chan AM. R-Ras is required for murine dendritic cell maturation and CD4+ T-cell priming. Blood. 119: 1693-701. PMID 22174156 DOI: 10.1182/Blood-2011-05-357319 |
0.774 |
|
| 2012 |
Chow A, Huggins M, Ahmed J, Lucas D, Hashimoto D, Kunisaki Y, Pinho S, Leboeuf M, Noizat C, van Rooijen N, Tanaka M, Zhao ZJ, Bergman A, Merad M, Frenette PS. CD169+ Macrophages Regulate Erythropoiesis Under Homeostasis, Recovery From Erythron Injury and in JAK2V617F-Induced Polycythemia Vera Blood. 120: 80-80. DOI: 10.1182/Blood.V120.21.80.80 |
0.798 |
|
| 2011 |
Hashimoto D, Miller J, Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity. 35: 323-35. PMID 21943488 DOI: 10.1016/J.Immuni.2011.09.007 |
0.636 |
|
| 2011 |
Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, Ginhoux F, Ochando JC, Kunisaki Y, van Rooijen N, Liu C, Teshima T, Heeger PS, Stanley ER, Frenette PS, et al. Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. The Journal of Experimental Medicine. 208: 1069-82. PMID 21536742 DOI: 10.1084/Jem.20101709 |
0.81 |
|
| 2011 |
Hashimoto D, Merad M. Harnessing dendritic cells to improve allogeneic hematopoietic cell transplantation outcome. Seminars in Immunology. 23: 50-7. PMID 21316261 DOI: 10.1016/J.Smim.2011.01.005 |
0.576 |
|
| 2011 |
Chow A, Lucas D, Hidalgo A, Méndez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N, Tanaka M, Merad M, Frenette PS. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. The Journal of Experimental Medicine. 208: 261-71. PMID 21282381 DOI: 10.1084/Jem.20101688 |
0.728 |
|
| 2011 |
Saenger YM, Pan M, Hashimoto D, Glodny B, Shah S, Houghton AN, Merghoub T, Wolchok JD, Merad M. Abstract 4742: Anti-tyrosinase related protein 1 (TRP1) antibody combined with cyclophosphamide induces adaptive immunity against melanoma Cancer Research. 71: 4742-4742. DOI: 10.1158/1538-7445.Am2011-4742 |
0.55 |
|
| 2010 |
Garcia MR, Ledgerwood L, Yang Y, Xu J, Lal G, Burrell B, Ma G, Hashimoto D, Li Y, Boros P, Grisotto M, van Rooijen N, Matesanz R, Tacke F, Ginhoux F, et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. The Journal of Clinical Investigation. 120: 2486-96. PMID 20551515 DOI: 10.1172/Jci41628 |
0.687 |
|
| 2010 |
Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K, Tanimoto M, Teshima T. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. The Journal of Clinical Investigation. 120: 2370-8. PMID 20530875 DOI: 10.4044/Joma.124.5 |
0.388 |
|
| 2010 |
Hashimoto D, Chow A, Greter M, Leboeuf M, Ginhoux F, Teshima T, Merad M. Pre-Transplant CSF-1 Therapy Expands the Recipient Macrophage Pool and Modulates Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation Blood. 116: 242-242. DOI: 10.1182/Blood.V116.21.242.242 |
0.818 |
|
| 2010 |
Richter S, Platzer B, Waltenberger D, Woisetschläger M, Strobl H, Nagy L, Sathe P, Corcoran L, Wu L, Shortman K, Sasaki I, Hoshino K, Hamada E, Hirashima T, Kaisho T, ... ... Hashimoto D, et al. Dendritic cells: differentiation (WS-046) Chairpersons: Kayo Inaba, Laszlo Nagy International Immunology. 22. DOI: 10.1093/Intimm/Dxq310 |
0.777 |
|
| 2009 |
Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, Hashimoto D, Price J, Yin N, Bromberg J, Lira SA, Stanley ER, Nussenzweig M, Merad M. The origin and development of nonlymphoid tissue CD103+ DCs. The Journal of Experimental Medicine. 206: 3115-30. PMID 20008528 DOI: 10.1084/Jem.20091756 |
0.782 |
|
| 2009 |
Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, Liu K, Jakubzick C, Ingersoll MA, Leboeuf M, Stanley ER, Nussenzweig M, Lira SA, Randolph GJ, Merad M. Origin of the lamina propria dendritic cell network. Immunity. 31: 513-25. PMID 19733489 DOI: 10.1016/J.Immuni.2009.08.010 |
0.804 |
|
| 2009 |
Koyama M, Hashimoto D, Aoyama K, Matsuoka K, Karube K, Niiro H, Harada M, Tanimoto M, Akashi K, Teshima T. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. Blood. 113: 2088-95. PMID 19144988 DOI: 10.1182/Blood-2008-07-168609 |
0.491 |
|
| 2009 |
Aoyama K, Koyama M, Matsuoka K, Hashimoto D, Ichinohe T, Harada M, Akashi K, Tanimoto M, Teshima T. Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens. Blood. 113: 1829-33. PMID 19124834 DOI: 10.1182/Blood-2008-05-155283 |
0.361 |
|
| 2008 |
Takashima S, Aoyama K, Koyama M, Hashimoto D, Oshima T, Tomizuka K, Akashi K, Teshima T. Protection of the Intestinal Epithelium from Conditioning with R-spondin1 Ameliorates Graft-Versus-Host Disease Blood. 112: 66-66. DOI: 10.1182/Blood.V112.11.66.66 |
0.342 |
|
| 2007 |
Maeda Y, Tawara I, Teshima T, Liu C, Hashimoto D, Matsuoka K, Tanimoto M, Reddy P. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease. Experimental Hematology. 35: 274-86. PMID 17258076 DOI: 10.1016/J.Exphem.2006.10.010 |
0.416 |
|
| 2007 |
Hashimoto D, Asakura S, Matsuoka K, Sakoda Y, Koyama M, Aoyama K, Tanimoto M, Teshima T. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease. European Journal of Immunology. 37: 271-81. PMID 17154260 DOI: 10.1002/Eji.200636123 |
0.37 |
|
| 2007 |
Sakoda Y, Hashimoto D, Asakura S, Takeuchi K, Harada M, Tanimoto M, Teshima T. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood. 109: 1756-64. PMID 17032915 DOI: 10.1182/Blood-2006-08-042853 |
0.39 |
|
| 2007 |
Aoyama K, Matsuoka K, Hashimoto D, Ichinohe T, Harada M, Tanimoto M, Teshima T. Breast-Feeding Mediates Feto-Maternal Tolerance and Improves Outcome of Allogeneic Bone Marrow Transplantation. Blood. 110: 2165-2165. DOI: 10.1182/Blood.V110.11.2165.2165 |
0.432 |
|
| 2007 |
Koyama M, Hashimoto D, Aoyama K, Matsuoka K, Karube K, Takeda K, Ohshima K, Akashi K, Tanimoto M, Harada M, Teshima T. Host Plasmacytoid or Conventional Dendritic Cells Alone Are Sufficient To Initiate Graft-Versus-Host Disease. Blood. 110: 2164-2164. DOI: 10.1182/Blood.V110.11.2164.2164 |
0.474 |
|
| 2007 |
Koyama M, Hashimoto D, Kamezaki K, Numata A, Sakoda Y, Aoyama K, Takenaka K, Miyamoto T, Harada N, Nagafuji K, Akashi K, Tanimoto M, Harada M, Teshima T. 351: Early recovery of host T cells predicts primary graft rejection following non-myeloablative conditioning allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation. 13: 127. DOI: 10.1016/J.Bbmt.2006.12.356 |
0.355 |
|
| 2007 |
Hashimoto D, Asakura S, Matsuoka K, Sakoda Y, Koyama M, Aoyama K, Tanimoto M, Teshima T. 298: Alloantigens expression on host non-hematopoietic cells leads to donor T cell exhaustion and reduces GVL effects Biology of Blood and Marrow Transplantation. 13: 108. DOI: 10.1016/J.Bbmt.2006.12.303 |
0.383 |
|
| 2007 |
Sakoda Y, Hashimoto D, Asakura S, Takeuchi K, Harada M, Tanimoto M, Teshima T. 36: Donor-reactive thymic-dependent Th1 cells cause chronic GVHD Biology of Blood and Marrow Transplantation. 13: 16. DOI: 10.1016/J.Bbmt.2006.12.039 |
0.33 |
|
| 2006 |
Yoshida I, Matsuo K, Teshima T, Hashimoto D, Tanimoto Y, Harada M, Tanimoto M. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation. Transfusion. 46: 186-92. PMID 16441593 DOI: 10.1111/J.1537-2995.2006.00700.X |
0.348 |
|
| 2006 |
Matsuoka K, Ichinohe T, Hashimoto D, Asakura S, Tanimoto M, Teshima T. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism. Blood. 107: 404-9. PMID 16150938 DOI: 10.1182/Blood-2005-07-3045 |
0.432 |
|
| 2005 |
Hashimoto D, Asakura S, Miyake S, Yamamura T, Van Kaer L, Liu C, Tanimoto M, Teshima T. Stimulation of host NKT cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. Journal of Immunology (Baltimore, Md. : 1950). 174: 551-6. PMID 15611282 DOI: 10.4049/Jimmunol.174.1.551 |
0.403 |
|
| 2005 |
Sakoda Y, Hashimoto D, Takeuchi K, Asakura S, Akashi K, Tanimoto M, Harada M, Teshima T. Impaired Thymic Negative Selection Causes Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation. Blood. 106: 453-453. DOI: 10.1182/Blood.V106.11.453.453 |
0.378 |
|
| 2005 |
Maeda Y, Teshima T, Hashimoto D, Tanimoto M, Reddy P. Homeostatic Proliferation of Donor T Cells Reduces Their Capacity for Inducing Acute Graft-Versus-Host Disease. Blood. 106: 1301-1301. DOI: 10.1182/Blood.V106.11.1301.1301 |
0.431 |
|
| 2004 |
Asakura S, Hashimoto D, Matsuoka K, Sakoda Y, Tanimoto M, Teshima T. Alloantigen Expression on Host Target Epithelium Inhibits Graft-Versus-Leukemia (GVL) Effects. Blood. 104: 596-596. DOI: 10.1182/Blood.V104.11.596.596 |
0.368 |
|
| 2004 |
Hashimoto D, Asakura S, Matsuoka K, Sakoda Y, Tanimoto M, Teshima T. FTY720-Induced Sequestration of Donor T Cells in Lymph Nodes Leads to Activation-Induced Apoptosis of Alloreactive T Cells and Reduced Graft-Versus-Host Disease. Blood. 104: 3061-3061. DOI: 10.1182/Blood.V104.11.3061.3061 |
0.397 |
|
| 2002 |
Yoshida C, Kojima K, Shinagawa K, Hashimoto D, Asakura S, Takata S, Tanimoto M. Fournier's gangrene after unrelated cord blood stem cell transplantation. Annals of Hematology. 81: 538-9. PMID 12373358 DOI: 10.1007/S00277-002-0525-9 |
0.318 |
|
| Show low-probability matches. |